samedan logo
 
 
 
spacer
home > ebr > winter 2001 > the credibility gap - intellectual property rights, access to drugs and bioterrorism
PUBLICATIONS
European Biopharmaceutical Review

The Credibility Gap - Intellectual Property Rights, Access to Drugs and Bioterrorism

The issue of intellectual property rights (IPR) and access to drugs has once again been thrown under the spotlight as a result of the recent bioterrorist attacks on the US - but this time with an ironic twist: it has been the very countries that blocked the efforts of developing nations to override IPR to obtain access to key drugs that have recently threatened to do just that. So, in an attempt to procure mass quantities of antibiotics with which to treat anthrax poisoning - and amid threats to contract generic firms to ensure adequate supplies of Bayer AG's drug Cipro/Ciprobay (ciprofloxacin) - did the US and Canada undermine long-held positions and political credibility on pharmaceutical IPR in the run-up to the World Trade Organization (WTO) negotiations in Doha (Qatar, 9th-14th November)?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Henry Dummett, Africa and North America Analyst for World Markets Healthcare

Henry Dummett is the Africa and North America analyst for World Markets Healthcare, the new analytical information service for the global healthcare market from the World Markets Research Centre (WMRC). Henry is a graduate in Modern History from St. Anne's College, Oxford and has an MSc in African Politics from the School of Oriental and African Studies (SOAS).

spacer
Henry Dummett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Bio-Rad Launches Its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics

HERCULES, Calif.–October 21, 2021–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System
More info >>

White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement